A thousand years of pulmonary medicine: good news and bad

Murray J.F.

Source: Eur Respir J 2001; 17: 558-565
Journal Issue: March

PDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Murray J.F.. A thousand years of pulmonary medicine: good news and bad. Eur Respir J 2001; 17: 558-565

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung cancer assessment clinics: the fast track to bad news?
Source: Eur Respir J 2005; 26: Suppl. 49, 323s
Year: 2005

Good news about a bad subject: scientific evidence to help defeat multidrug/extensively drug-resistant tuberculosis
Source: Eur Respir J 2014; 44: 5-7
Year: 2014


When and how to communicate bad news to our patients
Source: International Congress 2016 – When respiratory disease come to an end
Year: 2016


E-learning course on COPD prevention for Russian GP: what do the doctors say?
Source: Annual Congress 2007 - Smoking and the lung
Year: 2007


ß2-agonists do not work in children under 2 years of age: myth or maxim?
Source: Breathe, 15 (4) 273; 10.1183/20734735.0255-2019
Year: 2019



Communication of bad news: do regional differences exist in Europe and around the world?
Source: ERS Online Course 2016
Year: 2016

Foundation doctor knowledge of inhaled devices - Are the old better than the new?
Source: International Congress 2016 – Abstracts in medical education, the web and the internet
Year: 2016


What happens to COPD patient during the last few years of their life?
Source: Eur Respir J 2003; 22: Suppl. 45, 353s
Year: 2003

Handout How to deliver bad news
Source: Amsterdam 2015 - Educational material
Year: 2015

Fifteen years of LTOT in Slovenia: current satisfaction?
Source: Eur Respir J 2004; 24: Suppl. 48, 518s
Year: 2004

Precision medicine in COPD: where are we and where do we need to go?
Source: Eur Respir Rev, 27 (149) 180022; 10.1183/16000617.0022-2018
Year: 2018



Antibiotics in acute exacerbations of COPD: the good, the bad and the ugly
Source: Eur Respir J 2012; 40: 1-3
Year: 2012


"Don’t get me wrong, I think case finding is okay" Exploring healthcare professionals’ perspectives on target case-finding for COPD
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016

Proposed new pulmonary hypertension definition: is 4 mm(Hg) worth re-writing medical textbooks?
Source: Eur Respir J, 53 (3) 1900197; 10.1183/13993003.00197-2019
Year: 2019



New inhaler devices: the good, the bad, and the ugly
Source: International Congress 2015 – Inhaled drugs: within and beyond the lungs
Year: 2015

Door to NIV time: A tale of three audits over 4 years – Are we getting better?
Source: Annual Congress 2013 –New evidence for NIV in the acute setting
Year: 2013


Communication skills in end-stage respiratory disease: managing distressed patients and breaking bad news
Source: Breathe 2008; 5: 146-154
Year: 2008

The best papers in the ERJ: paediatric pulmonary diseases
Source: Virtual Congress 2020 – The European Respiratory Journal editor's view: our best papers of last year
Year: 2020


Spirometry in primary care: is it good enough to face demands like World COPD Day?
Source: Eur Respir J 2003; 22: 725-727
Year: 2003